{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:51:13Z","timestamp":1790171473301,"version":"4.1.0"},"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T00:00:00Z","timestamp":1408320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0104850","type":"journal-article","created":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T19:31:38Z","timestamp":1408390298000},"page":"e104850","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Cardiac Sympathetic Denervation in 6-OHDA-Treated Nonhuman Primates"],"prefix":"10.1371","volume":"9","author":[{"given":"Valerie","family":"Joers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Dilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrose","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Shultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina E.","family":"Emborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/01.wnl.0000268696.57912.64","article-title":"Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation","volume":"69","author":"DS Goldstein","year":"2007","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/mds.23773","article-title":"Olfactory deficits and cardiac 123I-MIBG in Parkinson&apos;s disease related to the LRRK2 R1441G and G2019S mutations","volume":"26","author":"J Ruiz-Martinez","year":"2011","journal-title":"Mov Disord"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-133-5-200009050-00009","article-title":"Cardiac sympathetic denervation in Parkinson disease","volume":"133","author":"DS Goldstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"ref4","first-page":"153","article-title":"Cardiovascular autonomic dysfunction in parkinsonian patients","volume":"5","author":"CJ Mathias","year":"1998","journal-title":"Clin Neurosci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/archneurol.2010.135","article-title":"When does Parkinson disease start?","volume":"67","author":"R Savica","year":"2010","journal-title":"Arch Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.24954","article-title":"Premotor Parkinson&apos;s disease: concepts and definitions","volume":"27","author":"A Siderowf","year":"2012","journal-title":"Mov Disord"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mds.870120607","article-title":"Symptoms and duration of the prodromal phase in Parkinson&apos;s disease","volume":"12","author":"EG Gonera","year":"1997","journal-title":"Mov Disord"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2007.06.007","article-title":"The premotor phase of Parkinson&apos;s disease","volume":"13","author":"E Tolosa","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10286-007-0396-1","article-title":"Cardiac sympathetic denervation preceding motor signs in Parkinson disease","volume":"17","author":"DS Goldstein","year":"2007","journal-title":"Clin Auton Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1212\/01.WNL.0000058766.46428.F3","article-title":"Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension","volume":"60","author":"DS Goldstein","year":"2003","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","article-title":"Orthostatic hypotension from sympathetic denervation in Parkinson&apos;s disease","volume":"58","author":"DS Goldstein","year":"2002","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00002826-199302000-00008","article-title":"Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy","volume":"16","author":"JM Senard","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"ref13","first-page":"125","article-title":"Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson&apos;s disease","volume":"4","author":"V Joers","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1750-3639.2005.tb00097.x","article-title":"Profound cardiac sympathetic denervation occurs in Parkinson disease","volume":"15","author":"T Amino","year":"2005","journal-title":"Brain Pathol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/jnnp.73.6.776","article-title":"Sympathetic cardiac denervation in Parkinson&apos;s disease and pure autonomic failure but not in multiple system atrophy","volume":"73","author":"S Orimo","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2005.11.034","article-title":"Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease","volume":"243","author":"J Mitsui","year":"2006","journal-title":"J Neurol Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1212\/WNL.52.6.1269","article-title":"Lewy body-type degeneration in cardiac plexus in Parkinson&apos;s and incidental Lewy body diseases","volume":"52","author":"K Iwanaga","year":"1999","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000113469","article-title":"Neuropathology of autonomic nervous system in Parkinson&apos;s disease","volume":"38","author":"K Wakabayashi","year":"1997","journal-title":"Eur Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/nen.0b013e3180517454","article-title":"Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in lewy body disease","volume":"66","author":"Y Fumimura","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archneur.57.10.1461","article-title":"Acute orthostatic hypotension when starting dopamine agonists in Parkinson&apos;s disease","volume":"57","author":"K Kujawa","year":"2000","journal-title":"Arch Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0031-6997(25)06677-3","article-title":"Pharmacological actions of 6-hydroxydopamine","volume":"26","author":"RM Kostrzewa","year":"1974","journal-title":"Pharmacol Rev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3565(25)27139-7","article-title":"The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine","volume":"150","author":"CC Porter","year":"1965","journal-title":"J Pharmacol Exp Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0022-3565(25)26555-7","article-title":"Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice","volume":"140","author":"CC Porter","year":"1963","journal-title":"J Pharmacol Exp Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF03165394","article-title":"Uptake and washout of I-123-MIBG in neuronal and non-neuronal sites in rat hearts: relationship to renal clearance","volume":"10","author":"AS Arbab","year":"1996","journal-title":"Ann Nucl Med"},{"key":"ref25","first-page":"1490","article-title":"Dependence of cardiac 11C-meta-hydroxyephedrine retention on norepinephrine transporter density","volume":"47","author":"DM Raffel","year":"2006","journal-title":"J Nucl Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.RES.31.2.207","article-title":"Acute and chronic cardiovascular effects of 6-hydroxydopamine in dogs","volume":"31","author":"P Gauthier","year":"1972","journal-title":"Circ Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004872-199105000-00005","article-title":"Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine","volume":"9","author":"DS Goldstein","year":"1991","journal-title":"J Hypertens"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1124\/jpet.103.051714","article-title":"Sympathetic innervation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson&apos;s disease","volume":"306","author":"DS Goldstein","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e35371","DOI":"10.1371\/journal.pone.0035371","article-title":"Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys","volume":"7","author":"V Joers","year":"2012","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ilar.48.4.339","article-title":"Nonhuman primate models of Parkinson&apos;s disease","volume":"48","author":"ME Emborg","year":"2007","journal-title":"ILAR J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1258\/002367780781071166","article-title":"Calcification in the adrenals and ovaries of monkeys","volume":"14","author":"SK Majeed","year":"1980","journal-title":"Lab Anim"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1258\/002367794781065834","article-title":"Calcified foci at the junction between adrenal cortex and medulla of rhesus monkeys","volume":"28","author":"A Kast","year":"1994","journal-title":"Lab Anim"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/030098588502200208","article-title":"Adrenal lesions in the baboon (Papio spp)","volume":"22","author":"PN Skelton-Stroud","year":"1985","journal-title":"Vet Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1365-2990.2011.01194.x","article-title":"Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson&apos;s disease","volume":"37","author":"S Orimo","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-009-0596-y","article-title":"Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson&apos;s disease: an anatomical study","volume":"118","author":"E Ghebremedhin","year":"2009","journal-title":"Acta Neuropathol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s003800300005","article-title":"Histological study on the distribution of autonomic nerves in the human heart","volume":"18","author":"H Kawano","year":"2003","journal-title":"Heart Vessels"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1152\/japplphysiol.01013.2009","article-title":"An unbiased stereological method for efficiently quantifying the innervation of the heart and other organs based on total length estimations","volume":"108","author":"C Muhlfeld","year":"2010","journal-title":"J Appl Physiol (1985)"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1476-5381.1965.tb01745.x","article-title":"Action of 2, 4, 5-Trihydroxyphenylethylamine on the Storage and Release of Noradrenaline","volume":"24","author":"R Laverty","year":"1965","journal-title":"Br J Pharmacol Chemother"},{"key":"ref39","first-page":"1620","article-title":"Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function","volume":"28","author":"JC Sisson","year":"1987","journal-title":"J Nucl Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neures.2007.11.011","article-title":"Myocardial nerve fibers are preserved in MPTP-treated mice, despite cardiac sympathetic dysfunction","volume":"60","author":"T Amino","year":"2008","journal-title":"Neurosci Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"V Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson&apos;s disease-related pathology","volume":"318","author":"H Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00392-010-0170-6","article-title":"Parasympathetic but not sympathetic cardiac dysfunction at early stages of Parkinson&apos;s disease","volume":"99","author":"A Buob","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/mds.22226","article-title":"Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson&apos;s disease with orthostatic hypotension","volume":"23","author":"Y Sharabi","year":"2008","journal-title":"Mov Disord"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1148\/radiol.12112723","article-title":"Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET","volume":"265","author":"KK Wong","year":"2012","journal-title":"Radiology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0735-1097(93)90553-D","article-title":"Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography","volume":"22","author":"KC Allman","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"ref47","first-page":"1985","article-title":"Regional abnormality of iodine-123-MIBG in diabetic hearts","volume":"37","author":"N Hattori","year":"1996","journal-title":"J Nucl Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mds.10461","article-title":"Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson&apos;s disease","volume":"18","author":"F Courbon","year":"2003","journal-title":"Mov Disord"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ana.10236","article-title":"Progressive loss of cardiac sympathetic innervation in Parkinson&apos;s disease","volume":"52","author":"ST Li","year":"2002","journal-title":"Ann Neurol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1083\/jcb.108.2.613","article-title":"Posttranslational membrane attachment and dynamic fatty acylation of a neuronal growth cone protein, GAP-43","volume":"108","author":"JH Skene","year":"1989","journal-title":"J Cell Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.RES.86.7.816","article-title":"Nerve sprouting and sudden cardiac death","volume":"86","author":"JM Cao","year":"2000","journal-title":"Circ Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0006-8993(75)90029-3","article-title":"Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny","volume":"99","author":"C Sachs","year":"1975","journal-title":"Brain Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0361-9230(92)90142-K","article-title":"Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain","volume":"29","author":"AS Perumal","year":"1992","journal-title":"Brain Res Bull"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1046\/j.1471-4159.1995.64041703.x","article-title":"Free radical-generated neurotoxicity of 6-hydroxydopamine","volume":"64","author":"R Kumar","year":"1995","journal-title":"J Neurochem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2005.06.020","article-title":"Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats","volume":"1052","author":"C Henze","year":"2005","journal-title":"Brain Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.106.119206","article-title":"Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum","volume":"322","author":"T Kawasaki","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-8-91","article-title":"The PPAR-gamma agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys","volume":"8","author":"CR Swanson","year":"2011","journal-title":"J Neuroinflammation"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1460-9568.2005.04281.x","article-title":"6-Hydroxydopamine-induced alterations in blood-brain barrier permeability","volume":"22","author":"PM Carvey","year":"2005","journal-title":"Eur J Neurosci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","article-title":"Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging","volume":"15","author":"F Cicchetti","year":"2002","journal-title":"Eur J Neurosci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0006-8993(89)90857-3","article-title":"Microglial response to 6-hydroxydopamine-induced substantia nigra lesions","volume":"489","author":"H Akiyama","year":"1989","journal-title":"Brain Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1332.007","article-title":"Inflammation and the degenerative diseases of aging","volume":"1035","author":"PL McGeer","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"L Maroteaux","year":"1988","journal-title":"J Neurosci"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10048-008-0124-6","article-title":"Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease","volume":"9","author":"K Beyer","year":"2008","journal-title":"Neurogenetics"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"MG Spillantini","year":"1997","journal-title":"Nature"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","article-title":"The Lewy body in Parkinson&apos;s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates","volume":"27","author":"K Wakabayashi","year":"2007","journal-title":"Neuropathology"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1523\/JNEUROSCI.0482-05.2005","article-title":"Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells","volume":"25","author":"WW Smith","year":"2005","journal-title":"J Neurosci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"H Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"TG Beach","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2012.07.005","article-title":"Alpha-synuclein aggregates in epicardial fat tissue in living subjects without parkinsonism","volume":"19","author":"J Navarro-Otano","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"M Vila","year":"2000","journal-title":"J Neurochem"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.nbd.2005.05.028","article-title":"Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates","volume":"20","author":"MG Purisai","year":"2005","journal-title":"Neurobiol Dis"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001756-200001170-00041","article-title":"MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons","volume":"11","author":"NW Kowall","year":"2000","journal-title":"Neuroreport"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJM198801283180415","article-title":"Decreased catecholamines in the adrenal medulla of patients with parkinsonism","volume":"318","author":"SW Carmichael","year":"1988","journal-title":"N Engl J Med"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0014-4886(89)90032-0","article-title":"Decreased adrenal medullary catecholamines in adrenal transplanted parkinsonian patients compared to nephrectomy patients","volume":"104","author":"SL Stoddard","year":"1989","journal-title":"Exp Neurol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.HYP.0000188052.69549.e4","article-title":"Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment","volume":"46","author":"DS Goldstein","year":"2005","journal-title":"Hypertension"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1046\/j.1471-4159.1999.0731024.x","article-title":"Localization of the noradrenaline transporter in rat adrenal medulla and PC12 cells: evidence for its association with secretory granules in PC12 cells","volume":"73","author":"AG Kippenberger","year":"1999","journal-title":"J Neurochem"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF01926498","article-title":"Selective destruction of adrenergic nerve terminals by chemical analogues of 6-hydroxydopamine","volume":"29","author":"JP Tranzer","year":"1973","journal-title":"Experientia"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1471-4159.1985.tb05491.x","article-title":"A comparison of the evolutionary distribution of the two neuroendocrine markers, neurone-specific enolase and protein gene product 9.5","volume":"45","author":"P Jackson","year":"1985","journal-title":"J Neurochem"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0014-5793(87)81327-3","article-title":"Molecular cloning of cDNA coding for human PGP 9.5 protein. A novel cytoplasmic marker for neurones and neuroendocrine cells","volume":"210","author":"IN Day","year":"1987","journal-title":"FEBS Lett"},{"key":"ref80","first-page":"213","article-title":"Localisation of chromogranin A and B, met-enkephalin-arg6-gly7-leu8 and PGP9.5-like immunoreactivity in the developing and adult rat adrenal medulla and extra-adrenal chromaffin tissue","volume":"166","author":"C Kent","year":"1989","journal-title":"J Anat"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1354\/vp.09-VP-0022-M-FL","article-title":"Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus)","volume":"46","author":"AD Miller","year":"2009","journal-title":"Vet Pathol"},{"key":"ref82","first-page":"609","article-title":"Lewy bodies in the visceral autonomic nervous system in Parkinson&apos;s disease","volume":"60","author":"K Wakabayashi","year":"1993","journal-title":"Adv Neurol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0006-8993(03)03040-3","article-title":"Alpha-synuclein expression localizes to the Golgi apparatus in bovine adrenal medullary chromaffin cells","volume":"984","author":"MM Tompkins","year":"2003","journal-title":"Brain Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0104850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:55:51Z","timestamp":1746345351000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0104850"}},"subtitle":[],"editor":[{"given":"Mal\u00fa G.","family":"Tansey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,18]]},"references-count":83,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0104850","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,18]]}}}